PEPFAR program marks 20 years, 20 million lives saved
PEPFAR was the largest public health effort by one country against a single disease, and as of late last year, has provided lifesaving treatment to more than 20 million people suffering from HIV/AIDS.
Failure of tuberculosis treatment linked to bacterial resilience
Researchers have discovered a new form of altered drug susceptibility—dubbed antibiotic resilience—that enables Mycobacterium tuberculosis to survive antibiotic treatment.
New tools for preventing the next pandemic
Technologies such as genomic sequencing have proved to be invaluable in responding to the COVID-19 pandemic and will be important in preventing future infectious disease outbreaks, according to the panel of experts who spoke at a Harvard T.H.…
Is new malaria vaccine ‘world-changing’? Maybe.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
Tracking and responding to the global monkeypox outbreak
Bill Hanage discusses the current state of the monkeypox outbreak and efforts to control disease spread.
Experts offer tips on taking COVID rapid tests
Experts have been urging people to take advantage of rapid COVID tests and have offered advice on how to use them most effectively.
A better antibiotic for tuberculosis treatment
PhD candidate Harim Won is developing a new type of antibiotic to address long-standing issues of lengthy treatments and drug resistance, using a new approach to turn a normal protein system in the bacterial cell against itself.
U.S. early warning system aims to track emerging health threats
Since August 2021, Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at Harvard Chan School, has been working to strengthen the U.S. early warning system for health threats as director for science…
Coronavirus (COVID-19): Press Conference with Stephen Kissler, 3/23/22
Stephen Kissler, research fellow in the Department of Immunology and Infectious Diseases, spoke on March 23rd.
‘The infectious disease that nobody ever thinks about’
To mark World TB Day, March 24, Harvard Chan School's Sarah Fortune, a TB expert, discusses the state of the disease worldwide, obstacles to fighting it, and the latest research.
